Display options
Cite
Brougher JT. Gene Patent Reform: Still in Doubt: The patent-eligibility doctrine remains in limbo as the battle over gene patents cuts a tortuous path through the court system. Biotechnol Healthc. 2011;8(4):28-9
Brougher, J. T. (2011). Gene Patent Reform: Still in Doubt: The patent-eligibility doctrine remains in limbo as the battle over gene patents cuts a tortuous path through the court system. Biotechnology healthcare, 8(4), 28-9.
Brougher, Joanna T. "Gene Patent Reform: Still in Doubt: The patent-eligibility doctrine remains in limbo as the battle over gene patents cuts a tortuous path through the court system." Biotechnology healthcare vol. 8,4 (2011): 28-9.
Brougher JT. Gene Patent Reform: Still in Doubt: The patent-eligibility doctrine remains in limbo as the battle over gene patents cuts a tortuous path through the court system. Biotechnol Healthc. 2011;8(4):28-9. PMID: 22479232; PMCID: PMC3278130.
Copy Download .nbib Format: NLM
Share it on

Biotechnol Healthc. 2011;8(4):28-9.

Gene Patent Reform: Still in Doubt: The patent-eligibility doctrine remains in limbo as the battle over gene patents cuts a tortuous path through the court system.

Biotechnology healthcare

Joanna T Brougher

PMID: 22479232 PMCID: PMC3278130

[No abstract available.]

Publication Types